Re: Group of Peruvian Amazon people 'resistant to rabies'
Published Date: 2012-08-05 09:36:07
Subject: PRO/AH> Rabies - Peru, comment
Archive Number: 20120805.1228965
RABIES - PERU, COMMENT
**********************
A ProMED-mail post
http://www.promedmail.org
ProMED-mail is a program of the
International Society for Infectious Diseases
http://www.isid.org
Date: Fri 3 Aug 2012
From: Steven Van Gucht [edited]
I would like to comment on the posting about the apparent abortive rabies virus infections observed in Peru [ProMED-mail archive no. 20120802.1226037].
The occurrence of such abortive infections is indeed a very interesting observation. I would like to add that there are some older reports that describe the occurrence of seropositive individuals in some populations at risk, which seem to have seroconverted without the development of brain disease:
T.C. Doege, R.L. Northrop, Evidence for inapparent rabies infection, Lancet 2 (1974) 826-829.
D. Black, T.J. Wiktor, Survey of raccoon hunters for rabies antibody titers: pilot study, J Fla Med Assoc 73 (1986) 517-520.
Actually, very little is known about the behaviour of the rabies virus in peripheral tissues before entry in the central nervous system. In mice, we observed that infection of macrophages might enhance the antibody response to the rabies virus, results are described in a paper that we recently submitted for publication.
--
Communicated by:
Steven Van Gucht
Head of Scientific Service
Viral Diseases | Communicable and Infectious Diseases
Scientific Institute of Public Health
Rue Engelandstraat 642 | 1180 Brussels, Belgium
[ProMED thanks Steven Van Gucht for his comments and the references about rabies antibodies in unvaccinated people. The biological significance of antibodies in the individuals remains to be determined, but one hopes that reports such as these will stimulate further research.
http://www.promedmail.org/direct.php?id=20120805.1228965
************************
Link to the open access full text article:
http://www.ajtmh.org/content/87/2/206.full
Abstract:
Evidence of Rabies Virus Exposure among Humans in the Peruvian Amazon
Amy T. Gilbert*,?, Brett W. Petersen?, Sergio Recuenco, Michael Niezgoda, Jorge G?mez, V. Alberto Laguna-Torres and Charles Rupprecht
In May of 2010, two communities (Truenococha and Santa Marta) reported to be at risk of vampire bat depredation were surveyed in the Province Datem del Mara??n in the Loreto Department of Per?. Risk factors for bat exposure included age less than or equal to 25 years and owning animals that had been bitten by bats. Rabies virus neutralizing antibodies (rVNAs) were detected in 11% (7 of 63) of human sera tested. Rabies virus ribonucleoprotein (RNP) immunoglobulin G (IgG) antibodies were detected in the sera of three individuals, two of whom were also seropositive for rVNA. Rabies virus RNP IgM antibodies were detected in one respondent with no evidence of rVNA or RNP IgG antibodies. Because one respondent with positive rVNA results reported prior vaccination and 86% (six of seven) of rVNA-positive respondents reported being bitten by bats, these data suggest nonfatal exposure of persons to rabies virus, which is likely associated with vampire bat depredation.
+ Author Affiliations
National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; Direcci?n General de Epidemiolog?a, Ministerio de Salud, Lima, Per?; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia; Virology Department, US Naval Medical Research Unit 6, Lima, Per?
+ Author Notes
Authors' addresses: Amy Gilbert, Brett Petersen, Sergio Recuenco, Michael Niezgoda, and Charles Rupprecht, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, E-mails:
fcj6@cdc.gov,
ige3@cdc.gov,
fni9@cdc.gov,
man6@cdc.gov, and
cyr5@cdc.gov. Jorge G?mez, Direcci?n General de Epidemiolog?a, Ministerio de Salud, Lima, Per?, E-mail:
jgomez@dge.gob.pe. V. Alberto Laguna-Torres, Virology Department, US Naval Medical Research Unit 6, Lima, Per?, E-mail:
alberto.laguna@med.navy.mil.
↵*Address correspondence to Amy Gilbert, Centers for Disease Control and Prevention, 1600 Clifton Rd, NE, Mailstop G33, Atlanta, GA 30333. E-mail:
fcj6@cdc.gov
↵?These authors contributed equally.